Citius Oncology, Inc. (CTOR) — Capital Reinvestment Ratio
Citius Oncology, Inc. (CTOR) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($900.29K) in capital expenditures ($0.46). See Citius Oncology, Inc. (CTOR) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Citius Oncology, Inc. Capital Reinvestment Ratio (2024–2024)
This chart tracks Citius Oncology, Inc.'s Capital Reinvestment Ratio across 1 annual periods. Check CTOR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Citius Oncology, Inc. (2024–2024)
Year-by-year Capital Reinvestment Ratio for Citius Oncology, Inc. from 2024 to 2024. For live market cap and broader valuation context, see Citius Oncology, Inc. (CTOR) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $126.35K | $4.00 | — |